Angeles Wealth Management’s DexCom DXCM Stock Holding History

Angeles Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,283	Closed	-$221K	–	471
2025 Q3	$221K	Sell	3,283 -614	-16%	-$48.6K	0.01%	309
2025 Q2	$340K	Buy	3,897 +641	+20%	+$50.2K	0.02%	235
2025 Q1	$222K	Buy	3,256 +111	+4%	+$9.06K	0.02%	268
2024 Q4	$245K	Buy	+3,145	New	+$233K	0.02%	254

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Angeles Wealth Management's DXCM Position: Q4 2025 in Review

Angeles Wealth Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 3,283 shares — an estimated $221K sold.

Angeles Wealth Management first reported a position in DXCM in Q4 2024 and held it in 4 quarters. The position peaked at $340K in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Angeles Wealth Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Angeles Wealth Management sold 3,283 DexCom shares in Q4 2025, an estimated $221K.
Angeles Wealth Management first reported a position in DexCom in Q4 2024 and held it in 4 quarters.
Angeles Wealth Management's DexCom position peaked at $340K in Q2 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Angeles Wealth Management's 13F filing for Q4 2025, filed 17 Feb 2026.